Mitesh

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on: Aripiprazole (Abilify and generic brands): risk of pathological gambling Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: December 2023 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 14 December 2023 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.

The October 2023 Drug Tariff was updated to include a deadline for submission of any outstanding referred back (unpaid) prescriptions to the NHS Business Services Authority (NHSBSA) for payment. Following this update, NHSBSA has seen a spike in the number of  referred back prescriptions submitted by pharmacies in the past month. The January 2024 Drug [...]

The post Reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Drug alert number: EL(23)A/43 Date issued: 13 December 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Company name: Atnahs [...]

The post Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP057 Estradot® 100mcg patches at 23.59pm on Friday 8 December 2023. After this date, any prescriptions for Estradot® 100mcg patches must be dispensed in accordance [...]

The post Expiry of SSP057 Estradot® 100mcg patches appeared first on Community Pharmacy England.